Own stem cells may slow progressive MS in small trial
NCT ID NCT04749667
First seen Mar 14, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This early-phase study tests whether a patient's own stem cells, injected into the spinal fluid, can repair nerve damage in people with progressive multiple sclerosis (MS). The trial involves 18 adults aged 18-55 with moderate to severe disability. The main goal is to see if the treatment improves nerve signals and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus university hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Vestland, Norway
-
St.Olav university hospital
Trondheim, Trøndelag, Norway
-
University hospital of North Norway
Tromsø, Troms Og Finnmark, Norway
Conditions
Explore the condition pages connected to this study.